Bridging the Gap Between Innovation and Capital
Norwest Venture Advisors
Focus on Biotech and Medtech companies
Program
Calling all early stage biotech, and medtech companies!
Norwest Venture Partners is a leading organization that supports early-stage ventures through late-stage growth. Biotech, Life Science, FinTech, PropTech, consumer products, B2B SaaS and more. Wherever you are, whatever you do, Norwest is always looking for smart investments, and we have the resources to help solve your unique challenges and reach your ultimate vision.
With a global presence, Norwest supports a wide variety of businesses. Managing $12.5B, with a current fund of $3B. Norwest has funded over 650 companies, with 200 currently active. What do they all have in common? The opportunity for massive growth, and a commitment to shared values.
Event
LaunchBio and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with Norwest.
Applications will be selected based on meeting the following criteria:
Geography:
Not restricted.
Company type:
Early-stage biotech and medtech companies..
Areas of Interest:
- Biotech
- Medtech
- Diagnostic
- Gene Therapy
- Research areas of interest include, (but not limited to):
- Neuroscience
- Genetics
- Oncology
- Immunology
- Ophthalmology
- Renal
- Drug Delivery
Stage:
Companies seeking funding for Seed, Series A and Series B and beyond. Companies with good clinical data looking to advance for FDA approval.
Qualifying start-ups can apply here today.
Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Silicon Valley Bank, a division of First Citizens Bank.